1-3 of 3
Muhit Ozcan, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.

Sule Mine Bakanay, MD, Klara Dalva, MD, Berna Elif Koksoy, MD, Erol Ayyildiz, Muhit Ozcan, M.D., Osman Ilhan, MD, Meral Beksac, MD
Journal: Blood
Blood (2012) 120 (21): 3024.
https://doi.org/10.1182/blood.V120.21.3024.3024
Published: 2012
Journal Articles

Immunophenotyping Features in Acute Myeloid Leukemia (AML) with NPM1+ and/or FLT3+

Pervin Topcuoglu, MD, Klara Dalva, PhD, MD, Sinem Civriz Bozdag, MD, Onder Arslan, MD, Muhit Ozcan, M.D., Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD
Journal: Blood
Blood (2011) 118 (21): 4908.
https://doi.org/10.1182/blood.V118.21.4908.4908
Published: 2011
Journal Articles

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndrome: A Retrospective Validation From a Single Centre.

Pervin Topcuoglu, MD, Klara Dalva, M.D., Sule Mine Bakanay, MD, Sinem Civriz Bozdag, M.D., Onder Arslan, M.D., Muhit Ozcan, M.D., Mutlu Arat, MD, Meral Beksac, MD, Gunhan Gurman, M.D.
Journal: Blood
Blood (2009) 114 (22): 4846.
https://doi.org/10.1182/blood.V114.22.4846.4846
Published: 2009